Our results build on previous evidence from bulk tissue at the protein and transcriptomic level that VEGFB, FLT1, FLT4, and NRP1 relate to the clinical progression and neuropathology of AD.16, 18. The gene discussed is NRP1; the disease is Alzheimer disease.